Sha Wu

Enhanced Apoptotic Death of Erythrocytes Induced by the Mycotoxin Ochratoxin A

Targeting Hypoxia-inducible Factor-1α With Tf–PEI–shRNA Complex via Transferrin Receptor–mediated Endocytosis Inhibits Melanoma Growth

Oncology Meets Immunology: The Cancer-Immunity Cycle

Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis

Cytokine patterns in patients with cancer: a systematic review

CXCR7 mediates TGFβ1-promoted EMT and tumor-initiating features in lung cancer

Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer

Age Sensitivity of NFκB Abundance and Programmed Cell Death in Erythrocytes Induced by NFκB Inhibitors

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death

Ochratoxin A activates opposing c-MET/PI3K/Akt and MAPK/ERK 1-2 pathways in human proximal tubule HK-2 cells

Toxicity of Ochratoxin A and Its Modulation by Antioxidants: A Review

Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives

Transforming growth factor-β1 upregulates the expression of CXC chemokine receptor 4 (CXCR4) in human breast cancer MCF-7 cells

Oxidative DNA damage is involved in ochratoxin A-induced G2 arrest through ataxia telangiectasia-mutated (ATM) pathways in human gastric epithelium GES-1 cells in vitro

Downregulation of transferrin receptor surface expression by intracellular antibody

Ochratoxin A induces oxidative DNA damage and G1 phase arrest in human peripheral blood mononuclear cells in vitro

Ochratoxin A induces G2 phase arrest in human gastric epithelium GES-1 cells in vitro